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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the
control.
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages
because growth is still exponential.
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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Situation and highlights 
The number of new cases in the 
EU+EFTA+UK countries has stuck at the 
level of 5,000 daily for more than 2 
weeks, as shown in the figure below, 
which corresponds to a degree of 3 in the 
Biocom-Cov scale.  Accordingly, ρ7 has 
been around 1 for the last 10 days, 
approximately.  
Right now, European countries are no 
longer the center of the pandemic. 
Globally, we have 21 countries with an 
average of new cases in the last 7 days 
over 1,000. At the top, we find Brazil 
with 25,000 new cases every day, 
followed by USA with 24,000. After 
them, there is India with 12,000 and 
Chile with 10,000. Among these 21 
countries, 7 are from the American 
continent (USA, Brazil, Chile, México, 
Perú, Colombia and Argentina) and 8 
from the Asian continent (India, Pakistan, 
Saudi Arabia, Bangladesh, Iran, Qatar, 
Iraq and Indonesia), 2 Africans (South 
Africa and Egypt) and 3 Europeans 
(Russia, UK and Sweden). The center of 
the pandemic is clearly the Americas, 
where there are more than 71,000 new 
cases daily, yet in the Asian countries 




The map in the left shows current A14. The map in the right shows current EPG.    
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(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, and distinguishes 
best (green) form worst (red) situations according to each of the variables. Last column (EPGEST) is assessed with estimated real 14-day attack rate (see report from 
22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST cannot be compared between them because scales are different, but can 
be independently used for estimating risk of countries according to reported or estimated real situation, respectively.    
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Analysis: On the update of historical series and its consequences on the analysis of 
data. 
The data management and information systems have been one of the main issues in many countries, during 
the pandemic. One of the causes behind these problems have been a lack of a common definition of Covid-
19 case and of Covid-19 death. Different countries have been reporting data with different meaning. Even 
inside some countries, different regions have reported cases and deaths without a generalized consensus. 
The definitions have gradually converged inside countries, where new protocols have successively 
implemented more precise definitions of confirmed and suspicious cases/deaths, but they still differ among 
countries.   
Another important challenge has been the huge initial delay between new infections and the final recording 
of these confirmed cases. Previous estimates of the group at the beginning of April (Report #381) valued 
these delays between the 7-8 days in countries like Germany, Ireland, Belgium or Austria, and the 13-14 days 
in countries like Portugal, Denmark, Spain, Italy or United Kingdom, among others. This means that data 
published every day were reflecting the situation of 1 to 2 weeks before. By that time, the main concerns of 
countries were related with the control of the outbreak, and the efforts on depurating and improving 
precision of datasets were necessarily postponed. In general, data series were built by the successive 
addition of new cases entering the system that were, by defect, assigned to the last day. This can lead to 
wrong conclusions when analysing this data series, as is the case of France. The one-day spikes shown in new 
cases do not correspond to new diagnoses that day, but to a set of old cases that are incorporated to the 
system.  
 
Germany was one of the first countries to assign new records to the day that the register belonged. This can 
be seen in the dashboard that is daily updated by Robert Kock Institute (RKI). The following figure shows a 
snapshot of this dashboard, obtained on 19th June from RKI website2. In blue, data series from yesterday. In 
yellow, new cases that have been added last 24 hours. As can be seen, most of new cases are assigned to last 
3 days, but a few of them are assigned to older dates (see yellow circles in figures).   
















At present, when most of countries are in the tail of the epidemic cycle with an incidence level that is 
acceptable by health and public health systems, the reliability of data series acquires importance. If the 
strategy of test and trace is expected to succeed, patients’ diagnosis and data recording of new cases must 
flow with a reasonable delay and precision. Many countries have put their efforts on revising the whole 
historical data set in order to (1) provide a better picture of what the situation has been last months, and (2) 
provide more precise data of current situation, so that its analysis gets more reliable and facilitates the 
control strategies. Besides, low incidence levels and a better situation of health system facilities have 
drastically reduced the delays and increased the percentage of cases that are diagnosed. In Spain, time 
since onset of symptoms and diagnosis have been reduced to 24-48 hours, according to authorities, while 
the percentage of diagnosed cases has doubled in two months (from 9-10 % to 18-20 %, according to 
authorities).  
Any improvement in this direction is good news, since it increases the precision of data and, therefore, the 
reliability of analyses. Nevertheless, this process may bring to light any inconsistency or delay that, two 
months ago, was masked by the situation. In particular, it is essential to determine the number of days at the 
end of a series that are not accurate because of unavoidable delays in diagnosis and recording. See, for 
instance, the case of Germany. As seen in previous figure, data from previous day were initially 
underestimated (blue) until they are updated today (yellow). If this information was not taken into account, 
one could have wrongly concluded that yesterday’s number of positives was lower than the one from the 
day before. This kind of dynamics may strongly affect the evaluation of the 7-day cumulative incidence, 
which is an indicator commonly considered by policy makers to assess the epidemiological situation of a 
region/country, as well as the estimation of the reproductive number. Therefore, in those countries where 
cases are situated at the right date, it is essential to evaluate the final period that cannot be considered for 
the analyses. 
One of the countries that is trying to correct the whole historical series is Spain. Last week, the Institute of 
Health Carlos III (ISCIII) published the revised series for all provinces, regions and the country. In these new 
series, cases are assigned to the date of symptoms onset. This allows to observe a more accurate picture of 
the epidemic. Nevertheless, the delay from the onset of symptoms to the record of the case must be assessed 
in order to properly work with these data. To this end, we have compared the historical series published on 
11th June (first series) with the one updated on 16th June (second series). Next figure shows the cases that 
were present in both series for the last weeks, the positives that were added by second series (in light blue) 
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and the cases that were moved from one day to another one (dark blue). The dotted line shows the day at 
which first series finishes. If no delays and corrections were expected, all new data should be after this line. 
 
We observe in this figure the overlay of two effects: the depuration of old series, that causes the modification 
of data even a few weeks before, and the delay between onset of symptoms and recording, which modifies 
last values. The first effect should disappear in a few days, when the complete series is revised. The second 
effect will persist, since it is inherent to the course of the disease and its diagnosis. Therefore, it is essential 
to determine how many of the last days must be discarded before analysing the series.  
From the figure, we can suspect a significant delay of 4 to 7 days. We can try to determine it in a more 
objective way by assessing the error as the cumulative difference of cases between both series divided by 
the cumulative number of cases reported by the updated one, starting from the end (tf) and going backwards.  
𝐸𝐸𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 (𝑡𝑡𝑓𝑓 − 𝑡𝑡) =
∑ 𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝑟𝑟𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷 𝐷𝐷𝐷𝐷 𝐷𝐷𝐷𝐷𝑛𝑛 𝐷𝐷𝑐𝑐𝑐𝑐𝐷𝐷𝑐𝑐 𝑏𝑏𝐷𝐷𝑡𝑡𝑛𝑛𝐷𝐷𝐷𝐷𝐷𝐷 𝑏𝑏𝑟𝑟𝑡𝑡ℎ 𝑐𝑐𝐷𝐷𝑟𝑟𝐷𝐷𝐷𝐷𝑐𝑐𝑡𝑡𝑓𝑓−𝑡𝑡𝑡𝑡𝑓𝑓
∑ 𝑁𝑁𝐷𝐷𝑛𝑛 𝐷𝐷𝑐𝑐𝑐𝑐𝐷𝐷𝑐𝑐 𝑟𝑟𝐷𝐷𝑟𝑟𝑟𝑟𝑟𝑟𝑡𝑡𝐷𝐷𝑟𝑟 𝑏𝑏𝑏𝑏 𝑐𝑐𝐷𝐷𝐷𝐷𝑟𝑟𝐷𝐷𝑟𝑟 𝑐𝑐𝐷𝐷𝑟𝑟𝐷𝐷𝐷𝐷𝑐𝑐𝑡𝑡𝑓𝑓−𝑡𝑡𝑡𝑡𝑓𝑓
 
We can impose that the error must be below 10 % in the whole series. We start evaluating this error for the 
whole series. If there are values above the 10 % threshold, we eliminate last day and evaluate the error again. 
If there are still values above the threshold, we eliminate two last days and repeat the process again. We 
keep on repeating this process as many times as necessary until the error remains below 10 % for the whole 
series. Doing so for the case of Spain, we must eliminate last 7 days. Therefore, this would be the number 
of days to be systematically eliminated before any analysis is carried out. Nevertheless, in the case of Spain, 
this is still affected by the depuration of old data. Therefore, this assessment should be repeated once the 




(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends in other countries 
Table of current situation in a sample of non-EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, 
and distinguishes best (green) form worst (red) situations according to each of the variables. EPGREP and EPGEST cannot be compared between them because scales 
are different, but can be independently used for estimating risk of countries according to reported or estimated real situation, respectively.    
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Time indicators by country 
These tables summarize a few time indicators for each country: time since 50 cases were reported, time 
interval between an attack rate of 1/105 inhabitants and an attack rate of 10/105 inhabitants, and time 






















Evaluated with the whole historical series. Up-left: Predictions of maximum incidences per country at the 
end of the first wave (total final expected attack rate per 105 inh.). Up-right: Predictions of maximum 
absolute number of cases per country at the end of the first wave (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date.  
 
 
Final expected value for EU+EFTA+UK as a whole is not shown any more, since we are in the tail (see 












Data from 9th June, series built with the day of symptoms’ onset 
 
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see 
report from 20 to 24 April, #37-41). This value can change in countries where suspicious deaths are reported as well 
(real values would be lower) and in countries where incidence among elderly people was minor (real values would be 
higher).  
 (1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the 
product of attack-rate of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). EPGEST is the product of 
estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, 
https://upcommons.upc.edu/handle/2117/189808). 
 
Long-term predictions are not shown any more, since all Italian and Spanish regions are already in the tail 






Legend: Countries’ reports details 

























reported cases.  
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 


































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 












































Data updated on 18th June, data series built 
with the day of the symptoms’ onset, reliable 










Data obtained from https://github.com/datadista/datasets/tree/master/COVID%2019 and 
https://covid19.isciii.es/  
 
(3) Analysis and prediction of COVID-19 



























































 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale  
 
(4) Analysis and prediction of COVID-19 

























































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports3, from European Centre 
for Disease Prevention and Control (ECDC)4 and from Ministerio de Sanidad5. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 








(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model6 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          




• Group A: prediction of expected cumulated cases for the following 3-5 days7; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors8 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
7 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
8 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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